Democrats are demanding federal investigations into whether President Trump received an experimental weight-loss drug through the FDA's compassionate use program — the same bureaucracy that fast-tracked COVID vaccines for millions of Americans under political pressure now apparently needs ironclad enforcement when a president's medical care is in question.

The selective outrage is the story. When the FDA cut corners to authorize COVID shots for the entire country under Operation Warp Speed, Democrats called it public health. When a president may have accessed a drug through a program the FDA itself administers, it's suddenly a scandal requiring congressional intervention.

STAT News reported Tuesday that a 79-year-old man was given an Eli Lilly weight-loss drug not yet approved by the FDA following a request made in April. Trump was 79 at the time. The report suggested the individual was Trump or someone close to him. The White House "aggressively" denied the story, according to Forbes, and called the STAT News reporter a "big idiot."

Sen. Maggie Hassan (D-N.H.) wrote to HHS Secretary Robert F. Kennedy Jr. that she was "deeply concerned" by reports suggesting Kennedy "may be bending the rules of a federal program, and exerting improper political pressure, in order to provide a well-connected individual with free access to an exclusive prescription drug," the Staten Island Advance reported.

The compassionate use program is designed for patients with serious or life-threatening conditions who have no other options. Whether Trump's treatment qualified is a fair question. What's not fair is the Democratic track record on FDA oversight.

Rep. Ted Lieu (D-Calif.) went further — much further. Without providing any evidence, Lieu suggested Trump may have canceled a bill signing ceremony because he was feeling side effects from the drug. Lieu also claimed Trump is suffering from a "terminal illness."

White House communications director Steven Cheung called Lieu a "dumbass" and said Liu "probably spent hours laughing to himself thinking that peddling this lie would be funny."

The Staten Island Advance framed this as legitimate oversight of a potentially bent rule. What it buried: the FDA's compassionate use program is used thousands of times a year, and the agency routinely exercises discretion on who qualifies. The Daily Beast, meanwhile, didn't touch the FDA story at all — it was busy covering Knicks players who might skip a White House visit and whether Trump's presence at Game 3 caused a "curse."

Here's the revolving door of selective outrage in one frame: the same Democrats who spent 2021 insisting any questioning of FDA vaccine authorization was dangerous misinformation now want you to believe the agency is a corrupt tool of political patronage. The question isn't whether Trump got a drug. It's why the rules only matter when they can be weaponized against him.

The FDA either has authority worth respecting across the board, or it's a political instrument. Democrats can't have both.